 |
| PUBLICATIONS |
On
this page... |
|
|
|
| |
| Click on desired publication
to link to abstract or associated file |
| |
Imaging an inflammatory response using 19F-MRI. Monterosso Tracey, Kaimal Vinod, McConville Patrick, Woolliscroft Michael, Mailliard Robbie, Nelson Aaron, Ahrens Eric, Barnard Cameron, Mobley James, Cornicelli Joseph. Inflammation Research Association. Abstract, September 2008.
Click
Here for Presented Poster
Click
Here for Speaker Presentation |
| |
| |
Structure-guided inhibitor design for human FAAH for interspecies active site conversion. Mauro Mileni, Douglas S. Johnson, Zhigang Wang, Daniel S. Everdeen, Marya Liimata, Brandon Pabst, Keshab Bhattacharya, Richard A. Nugent, Satwik Kamtekar, Benjamin F. Cravatt, Kay Ahn, and Raymond C. Stevens. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12820-4. Epub 2008 Aug 27.
|
| |
Activity of TG01, a selective COX-2 inhibitor, alone and in combination with standard agents in human breast carcinoma xenografts. Zaknoen S, Lawhon T, Meade M, Leopold R, Wong A, Meshaw K, Johnson R, Tragara Pharmaceuticals, San Diego, CA, MIR Preclinical Services, Ann Arbor, MI, Piedmont Research Center, Morrisville, NC, Independent Consultant, Santa Fe, NM, 2008 AACR Annual Meeting:5662, April 16, 2008. |
| |
Preclinical Models of Tumor Growth and Response. Elliott, W. L., Kreger, A. R., Lister, R. J., McConville, P., Moody, J. B., Trachet, E., Urban, F. and Leopold, W. R.. In Press, in “In Vivo Imaging of Cancer Therapy”, Anthony Shields and Pat Price (Editors), The Humana Press, 2005. |
| |
Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model og glioma.
McConville P, Hambardzumyan D, Moody JB, Leopold WR, Kreeger AR, Wooliscroft MJ, Rehemtulla A, Ross BD, Holland EC. Clinical Cancer Research,
13(10):2897-2904, May 15, 2007. |
| |
Vascular Targeted Nanoparticles for Imaging and Treatment.
Reddy GR, Bhojani MS, McConville P, Moody J, Moffat BA, Hall DE, Kim G, Koo YE, Woolliscroft MJ, Sugai JV, Johnson TD, Philbert MA, Kopelman R, Rehemtulla A, Ross BD. Clinical Cancer Research,
12(22):6677-86, November 15, 2006. |
|
Debate
Grows Over New Mouse Models of Cancer (Dr. Leopold quoted).
Ken Barber. Journal of the National Cancer Institute,
Vol. 98, No. 17, September 6, 2006. |
|
Diffusion MRI Early Prediction of Survival
using Solvent Facilitated
Perfusion of BCNU in a Rat Model of Glioma Perfusion
of BCNU in a Rat Model of Glioma. Patrick McConville,
Jonathan B. Moody, Richard J. Lister, William L. Elliott,
W. R. Leopold , Brian D. Ross, John M. Young and Edward
E. Luck. Am.
Assoc. Cancer Res, Abstract 2746, 2006.
Click
Here for Presented Poster |
| |
Efficacy
of temozolomide in a transgenic model of glioma: MRI
determined tumor growth inhibition and diffusion response
are predictive of survival. Patrick J. McConville, Jonathan
B. Moody, Alicia R. Kreger, William L. Elliott, Wilbur
R. Leopold, III and Eric C. Holland. Am.
Assoc. Cancer Res, Abstract 2756, 2006.
Click
Here for Presented Poster |
| |
Intratumoral
injection of BCNU in ethanol (DTI-015) and BCNU in ethanol/PEG400
cure subcutaneous C26 tumors. Richard J. Lister, Patrick
McConville, William L. Elliott, Wilbur R. Leopold, Brian
D. Ross, Alnawaz Rehemtulla, John M. Young and Edward
E. Luck. Am.
Assoc. Cancer Res, Abstract 5448, 2006.
Click
Here for Presented Poster |
| |
|
| |
MRI
Predicts Tumor Grade and Survival in a tv-a Transgenic
Model of Glioma. Jonathan B. Moody, Alicia Kreger, Patrick
McConville, Erin Trachet, Richard J. Lister, William
L. Elliott, W. R. Leopold and Eric C. Holland. Proceedings
of the Am. Assoc. Cancer Res, Abstract 1068, 2005.
Click
Here for Presented Poster |
| |
MRI
Determination of Temozolamide Treatment Response in
a tv-a Transgenic Model of Glioma. Patrick McConville,
Jonathan B. Moody, Alicia Kreger, Erin Trachet, Richard
J. Lister, William L. Elliott, W. R. Leopold and Eric
C. Holland. Proceedings of the Am. Assoc. Cancer Res,
Abstract 3787, 2005.
Click
Here for Presented Poster |
| |
Evaluation
of MRI in a Mouse Model of Liver Metastasis. Alicia
Kreger, Patrick McConville, William L. Elliott and W.
R. Leopold. Proceedings of the Am. Assoc. Cancer Res,
Abstract 3794, 2005.
Click
Here for Presented Poster |
| |
In
vivo Micro-CT of Mouse Lungs Without Respiratory Gating.
Erin Trachet, Jonathan B. Moody, Patrick McConville,
William L. Elliott and Wilbur R. Leopold. Proceedings
of the Am. Assoc. Cancer Res, Abstract 3795, 2005.
Click
Here for Presented Poster |
| |
In
Vivo Imaging of a Mouse Model of PC-3 Bone Metastasis.
Jonathan B. Moody, Richard Lister, Patrick McConville,
Alnawaz Rehemtulla, William L. Elliott and Wilbur R.
Leopold. Proceedings of the Am. Assoc. Cancer Res, 2005.
Click
Here for Presented Poster |
| |
Pyrido[2,3-d]pyrimidin-7-ones
as Specific Inhibitors of Cyclin-Dependent Kinase 4.
Scott N. Vanderwel, Patricia J. Harvey, Dennis J. McNamara,
Joseph T. Repine, Paul R. Keller, John Quin III, R.
John Booth, William L. Elliott, Ellen M. Dobrusin, David
W. Fry, and Peter L. Toogood. Journal of Medicinal Chemistry,
48(7): 2371-2387, April 7, 2005. |
| |
Specific
inhibition of cyclin-dependent kinase 4/6 by PD 0332991
and associated antitumor activity in human tumor xenografts.
David W. Fry, Patricia J. Harvey, Paul R. Keller, William
Elliott, MaryAnne Meade, Erin Trachet, Mudher Albassam,
XianXian Zheng, Wilbur R. Leopold, Nancy K. Pryer, and
Peter Toogood, Molecular Cancer Therapeutics, 3(11):1427-37,
November 2004. |
| |
High
field MRI characterization of tumor growth kinetics, vascularity
and cellularity in a PDGF-driven tv-a mouse model of glioma.
Patrick McConville, Jonathan B. Moody, Richard J. Lister,
Alicia Kreger, Erin Trachet, William L. Elliott, Brian
D. Ross and W. R. Leopold, EORTC-NCI-AACR, September,
2004.
|
| |
Assessment
of treatment efficacy in preclinical drug testing using
magnetic resonance imaging. Jonathan B. Moody, Patrick
McConville, Richard J. Lister, Alicia Kreger, Erin Trachet,
William L. Elliott, Brian D. Ross, Alnawaz Rehemtulla,
Eric C. Holland and W. R. Leopold, Assessment of treatment
efficacy in preclinical drug testing using magnetic resonance
imaging. EORTC-NCI-AACR, September, 2004. |
| |
MRI
characterization of tumor development in a tv-a transgenic
mouse model of glioma. Patrick McConville, Jonathan B.
Moody, Richard J. Lister, Alicia Kreger, Erin Trachet,
William L. Elliott, Brian D. Ross, Eric C. Holland and
W. R. Leopold, Proceedings of the 12th International Society
for Magnetic Resonance in Medicine (ISMRM), May 2004. |
| |
High
throughput MRI in the use and development of preclinical
mouse tumor models. Patrick McConville, Jonathan B.
Moody, Brian D. Ross and W. R. Leopold. Proceedings
of the Am. Assoc. Cancer Res., Volume 45, March 2004.
Click
Here for Presented Poster |
| |
High
field MRI characterization of tumor growth kinetics,
vascularity and cellularity in a PDGF-driven tv-a mouse
model of glioma. Patrick McConville, Jonathan B. Moody,
Richard J. Lister, Alicia Kreger, Erin Trachet, William
L. Elliott, Brian D. Ross, Eric C. Holland and W. R.
Leopold, Proceedings of the Am. Assoc. Cancer Res.,
Volume 45, March 2004.
Click
Here for Presented Poster |
| |
Diffusion
MRI in preclinical drug testing: an early surrogate
marker for efficacy in subcutaneous human tumor xenografts.
Jonathan B. Moody, Patrick McConville, Richard J. Lister,
Alicia Kreger, Erin Trachet, Daniel L. Dexter, William
L. Elliott, Bradford A. Moffat, Thomas L. Chenevert,
Brian D. Ross and W. R. Leopold, Proceedings of the
Am. Assoc. Cancer Res., Volume 45, March 2004.
Click
Here for Presented Poster |
| |
Diffusion
imaging for evaluation of tumor therapies in preclinical
animal models. Moffat B. A., Hall, D. E., Stojanovska,
J., McConville P., Moody, J. B., Chenevert T. L., Rehemtulla
A. and Ross B. D., MAGMA, 3:1-13, 2004. |
| |
Use
of Magnetic Resonance Imaging for Evaluation of Treatment
Response, in “Mouse Models of Human Cancer”.
Ross B. D., Chenevert T. L., Moffat B. A., Rehemtulla
A., Hall D.E., McConville P., Moody, J. B., Eric C. Holland
(Editor), Wiley, 2004. |
|
A
novel polyacrylamide magnetic nanoparticle contrast agent
for molecular imaging using MRI. Moffat B. A., Reddy G.
R., McConville P., Hall D.E., Chenevert T.L., Kopelman
R.R., Philbert M., Weissleder R., Rehemtulla A., Ross
B. D, Molecular Imaging. 2(4):324-32, 2003. |
|
Evaluation
of cancer therapy using diffusion magnetic resonance imaging.
Ross B. D., Moffat B. A., Lawrence T. S., Mukherji S.
K., Gebarski S. S., Quint D. J., Johnson T. D., Junck
L., Robertson PL, Muraszko K. M., Dong Q., Meyer C. R.,
Bland P. H., McConville P., Geng H., Rehemtulla A. and
Chenevert T. L., Molecular Cancer Therapeutics, 2(6):581-7,
2003. |
|
|
|
| |
|
|
|
|
|
